• ABOUT DRY EYE
  • Symptoms, Causes, and Diagnosis of Dry Eye
  • Treatments for Dry Eye
    • Artificial Tears
    • Prescription Options
    • Other Patient Options
• ABOUT LACRISERT^®
  • How LACRISERT^® Works
  • The Benefits of LACRISERT^®
  • Writing LACRISERT^®
  • How Patients Use LACRISERT^®
  • LACRISERT^® Efficacy Data
  • Patient Testimonials
• RESOURCES FOR YOU + YOUR PATIENTS
  • LACRISERT^® Sample Request
  • Customizable Tip Sheet
  • Aton Patient Savings Program
  • Aton PatientCARE^SM Program
  • Learn More About LACRISERT^®
  • Valuable Links
  • Presentations
• FAQs

Treatments for Dry Eye

Prescription Options

Two prescription options for your moderate to severe Dry Eye patients are:

• LACRISERT^®—A Dry Eye therapy that has been approved and used for over 25 years.¹ This once-daily,* slow-release insert improves tear film break-up time and relieves Dry Eye symptoms by helping the lacrimal glands, eye lids, and ocular surface to retain a more stable tear film for a longer period of time.^2,3 LACRISERT^® is the only prescription eye insert available in the United States
• Cyclosporine ophthalmic emulsion, 0.05%—A twice-a-day eyedrop that has been approved by the FDA for the treatment of ocular inflammation associated with keratoconjunctivitis sicca.^4,5 While LACRISERT^® has not been studied with cyclosporine ophthalmic emulsion, ophthalmologists have reported that they have successfully used the 2 therapies in combination.

Click here to see if LACRISERT^® is the right treatment option for your moderate to severe Dry Eye patients.

Click the following links to learn more about Dry Eye treatments:

• Artificial Tears
• Other Patient Options

LACRISERT^® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT^® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT^® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information
Do not use LACRISERT^® if you are allergic to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT^® should be carefully followed. If improperly placed, LACRISERT^® may result in a scratch to the cornea of your eye. Because LACRISERT^® may cause temporary blurred vision, please use caution when driving or operating machinery. Rubbing the eye(s) containing LACRISERT^® should be avoided. You should always discuss this safety information with your doctor. The following adverse reactions have been reported but were in most instances mild and temporary: temporary blurring of vision, eye discomfort or irritation, matting or stickiness of eyelashes, increased sensitivity to light, eyelid swelling, and eye redness. Talk to your doctor if you have side effects that bother you or that do not go away. You are encouraged to report side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

*For most Dry Eye sufferers, one LACRISERT^® inserted in each eye in the morning lasts the entire day. But some people may need to use it twice a day for symptom relief.²

References: 1. Data on File. Aton Pharma, Inc. 2. Lacrisert [prescribing information]. Lawrenceville, NJ: Aton Pharma, Inc; 2007. 3. The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5(2):75-92. Available at: http://www.tearfilm.org/dewsreport. Accessed January 5, 2009. 4. Drug Approvals–R. U.S. Food & Drug Administration Web site. Available at: www.fda.gov/cder/approval/r.htm. Accessed: January 9, 2009. 5. Restasis 0.05% [prescribing information]. Irvine, CA:Allergan, Inc; 2008.